US Stock MarketDetailed Quotes

EFTR eFFECTOR Therapeutics

Watchlist
  • 1.9800
  • 0.00000.00%
Close May 16 16:00 ET
9.31MMarket Cap-157P/E (TTM)

eFFECTOR Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-11.95%8.4M
4.45%33.84M
-1.43%8.6M
-15.09%7.86M
-0.33%7.86M
45.63%9.54M
1.59%32.4M
-29.66%8.72M
6.16%9.25M
56.25%7.88M
Selling and administrative expenses
5.57%3.09M
-13.59%10.93M
-8.15%2.52M
-28.28%2.5M
0.03%2.97M
-14.81%2.93M
-5.44%12.64M
-56.51%2.75M
-15.37%3.49M
78.67%2.97M
-General and administrative expense
5.57%3.09M
-13.59%10.93M
-8.15%2.52M
-28.28%2.5M
0.03%2.97M
-14.81%2.93M
-5.44%12.64M
-56.51%2.75M
-15.37%3.49M
78.67%2.97M
Research and development costs
-19.72%5.31M
-1.69%22.92M
-8.66%6.07M
-19.26%5.36M
-29.46%4.88M
112.37%6.61M
16.82%23.31M
4.00%6.65M
32.06%6.63M
69.92%6.92M
Other operating expenses
----
----
----
----
----
----
-148.46%-3.55M
-117.04%-675K
-103.04%-867K
-190.61%-2.01M
Operating profit
11.95%-8.4M
-4.45%-33.84M
1.43%-8.6M
15.09%-7.86M
0.33%-7.86M
-45.63%-9.54M
-1.59%-32.4M
29.66%-8.72M
-6.16%-9.25M
-56.25%-7.88M
Net non-operating interest income expense
7.99%-426K
-7.45%-1.95M
-9.63%-535K
-6.07%-454K
-12.24%-495K
-1.98%-463K
-3.07%-1.81M
-0.41%-488K
12.11%-428K
7.93%-441K
Non-operating interest income
42.92%323K
121.41%972K
6.70%223K
108.45%296K
254.69%227K
841.67%226K
7,216.67%439K
5,125.00%209K
14,100.00%142K
6,300.00%64K
Non-operating interest expense
8.71%749K
29.68%2.92M
8.75%758K
31.58%750K
42.97%722K
44.14%689K
27.61%2.25M
42.24%697K
16.80%570K
5.21%505K
Other net income (expense)
20.00%-12K
-100.17%-20K
106.12%3K
-95.00%6K
-101.00%-14K
-100.15%-15K
-76.64%11.55M
-100.15%-49K
-99.34%120K
5,728.00%1.41M
Special income (charges)
----
-99.95%6K
--0
-92.68%6K
--0
----
-74.96%12.12M
--0
-99.54%82K
--1.28M
-Less:Restructuring and merger&acquisition
----
99.95%-6K
--0
92.68%-6K
--0
----
75.21%-12.12M
--0
99.54%-82K
---1.28M
Other non- operating income (expenses)
20.00%-12K
95.47%-26K
106.12%3K
----
-111.38%-14K
97.81%-15K
-155.46%-574K
-106.00%-49K
-86.90%38K
592.00%123K
Income before tax
11.78%-8.83M
-58.00%-35.81M
1.40%-9.13M
13.14%-8.3M
-20.95%-8.36M
-426.30%-10.01M
-243.47%-22.67M
-148.61%-9.26M
-207.66%-9.56M
-24.64%-6.92M
Income tax
Net income
11.78%-8.83M
-58.00%-35.81M
1.40%-9.13M
13.14%-8.3M
-20.95%-8.36M
-426.30%-10.01M
-243.47%-22.67M
-148.61%-9.26M
-207.66%-9.56M
-24.64%-6.92M
Net income continuous Operations
11.78%-8.83M
-58.00%-35.81M
1.40%-9.13M
13.14%-8.3M
-20.95%-8.36M
-426.30%-10.01M
-243.47%-22.67M
-148.61%-9.26M
-207.66%-9.56M
-24.64%-6.92M
Minority interest income
Net income attributable to the parent company
11.78%-8.83M
-58.00%-35.81M
1.40%-9.13M
13.14%-8.3M
-20.95%-8.36M
-426.30%-10.01M
-243.47%-22.67M
-148.61%-9.26M
-207.66%-9.56M
-24.64%-6.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
11.78%-8.83M
-58.00%-35.81M
1.40%-9.13M
13.14%-8.3M
-20.95%-8.36M
-426.30%-10.01M
-243.47%-22.67M
-148.61%-9.26M
-207.66%-9.56M
-24.64%-6.92M
Basic earnings per share
63.76%-2.16
-18.97%-16.37
37.82%-3.42
43.48%-3.25
0.00%-4.25
-398.00%-5.96
-152.42%-13.76
-146.81%-5.5
-143.40%-5.75
-23.70%-4.25
Diluted earnings per share
63.76%-2.16
-18.97%-16.37
37.82%-3.42
43.48%-3.25
0.00%-4.25
-440.57%-5.96
-225.09%-13.76
-150.00%-5.5
-154.76%-5.75
-23.70%-4.25
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -11.95%8.4M4.45%33.84M-1.43%8.6M-15.09%7.86M-0.33%7.86M45.63%9.54M1.59%32.4M-29.66%8.72M6.16%9.25M56.25%7.88M
Selling and administrative expenses 5.57%3.09M-13.59%10.93M-8.15%2.52M-28.28%2.5M0.03%2.97M-14.81%2.93M-5.44%12.64M-56.51%2.75M-15.37%3.49M78.67%2.97M
-General and administrative expense 5.57%3.09M-13.59%10.93M-8.15%2.52M-28.28%2.5M0.03%2.97M-14.81%2.93M-5.44%12.64M-56.51%2.75M-15.37%3.49M78.67%2.97M
Research and development costs -19.72%5.31M-1.69%22.92M-8.66%6.07M-19.26%5.36M-29.46%4.88M112.37%6.61M16.82%23.31M4.00%6.65M32.06%6.63M69.92%6.92M
Other operating expenses -------------------------148.46%-3.55M-117.04%-675K-103.04%-867K-190.61%-2.01M
Operating profit 11.95%-8.4M-4.45%-33.84M1.43%-8.6M15.09%-7.86M0.33%-7.86M-45.63%-9.54M-1.59%-32.4M29.66%-8.72M-6.16%-9.25M-56.25%-7.88M
Net non-operating interest income expense 7.99%-426K-7.45%-1.95M-9.63%-535K-6.07%-454K-12.24%-495K-1.98%-463K-3.07%-1.81M-0.41%-488K12.11%-428K7.93%-441K
Non-operating interest income 42.92%323K121.41%972K6.70%223K108.45%296K254.69%227K841.67%226K7,216.67%439K5,125.00%209K14,100.00%142K6,300.00%64K
Non-operating interest expense 8.71%749K29.68%2.92M8.75%758K31.58%750K42.97%722K44.14%689K27.61%2.25M42.24%697K16.80%570K5.21%505K
Other net income (expense) 20.00%-12K-100.17%-20K106.12%3K-95.00%6K-101.00%-14K-100.15%-15K-76.64%11.55M-100.15%-49K-99.34%120K5,728.00%1.41M
Special income (charges) -----99.95%6K--0-92.68%6K--0-----74.96%12.12M--0-99.54%82K--1.28M
-Less:Restructuring and merger&acquisition ----99.95%-6K--092.68%-6K--0----75.21%-12.12M--099.54%-82K---1.28M
Other non- operating income (expenses) 20.00%-12K95.47%-26K106.12%3K-----111.38%-14K97.81%-15K-155.46%-574K-106.00%-49K-86.90%38K592.00%123K
Income before tax 11.78%-8.83M-58.00%-35.81M1.40%-9.13M13.14%-8.3M-20.95%-8.36M-426.30%-10.01M-243.47%-22.67M-148.61%-9.26M-207.66%-9.56M-24.64%-6.92M
Income tax
Net income 11.78%-8.83M-58.00%-35.81M1.40%-9.13M13.14%-8.3M-20.95%-8.36M-426.30%-10.01M-243.47%-22.67M-148.61%-9.26M-207.66%-9.56M-24.64%-6.92M
Net income continuous Operations 11.78%-8.83M-58.00%-35.81M1.40%-9.13M13.14%-8.3M-20.95%-8.36M-426.30%-10.01M-243.47%-22.67M-148.61%-9.26M-207.66%-9.56M-24.64%-6.92M
Minority interest income
Net income attributable to the parent company 11.78%-8.83M-58.00%-35.81M1.40%-9.13M13.14%-8.3M-20.95%-8.36M-426.30%-10.01M-243.47%-22.67M-148.61%-9.26M-207.66%-9.56M-24.64%-6.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 11.78%-8.83M-58.00%-35.81M1.40%-9.13M13.14%-8.3M-20.95%-8.36M-426.30%-10.01M-243.47%-22.67M-148.61%-9.26M-207.66%-9.56M-24.64%-6.92M
Basic earnings per share 63.76%-2.16-18.97%-16.3737.82%-3.4243.48%-3.250.00%-4.25-398.00%-5.96-152.42%-13.76-146.81%-5.5-143.40%-5.75-23.70%-4.25
Diluted earnings per share 63.76%-2.16-18.97%-16.3737.82%-3.4243.48%-3.250.00%-4.25-440.57%-5.96-225.09%-13.76-150.00%-5.5-154.76%-5.75-23.70%-4.25
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg